Andree Vandermeeren

Andree Vandermeeren, PhD, is an experienced clinical research professional with a robust background in site activation and regulatory affairs within the pharmaceutical industry. Currently serving as Associate Director in Site Activation for Oncology and Rare Diseases at Worldwide Clinical Trials, Andree leads project teams to achieve key performance indicators and is involved in developing site-specific activation plans. Previous roles include Senior Start Up Project Manager at Covance and Global Study Start Up Team Lead at ICON plc, overseeing international clinical projects and mentoring team members. Early career experience includes positions at Chiltern International and PharmaMar, focusing on regulatory submissions and clinical monitoring in oncology. Andree holds a PhD in Molecular Biology from Universidad Autónoma de Madrid and has a foundational education in Chemistry and Biochemistry from Université catholique de Louvain.